Natriuretic Peptide Receptor 1 antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Natriuretic Peptide Receptor 1 antagonist, covering 2026-02-10 to 2026-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS) [Phase 2]